FDA inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site): FDA inspection ending May 13, 2014
FDA inspection 880301 · No Action Indicated (NAI) · Lianyungang
Key facts
| Inspection ID | 880301 |
|---|---|
| Firm | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) |
| FEI number | 3007373503 |
| Address | Dev. Zone, Economic & Technological; 38 Huanghe Avenue |
| City | Lianyungang |
| Country | China |
| Fiscal year | 2014 |
| Inspection end date | May 13, 2014 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data